In vitro susceptibility of Plasmodium falciparum isolates from Gabon to chloroquine and cycloguanil;Sensibilité in vitro d'isolats gabonais de Plasmodium falciparum vis-à-vis de la chloroquine et du cycloguanil

Bulletin de la Societe de Pathologie Exotique

Volumn 92, Issue 2, 1999, Pages 91-94

  Pradines, B ^a   Mamfoumbi Mabika, M ^b   Keundjian, A ^a   Lebeau, C ^c   Fusai, T ^a   Owono Medang, M ^b   Rogier, C ^a   Parzy, D ^a   Kombila, M ^b  

^a SERVICE DE SANTÉ DES ARMÉES   (France)

^b UNIVERSITÉ DES SCIENCES DE LA SANTÉ   (Gabon)

^c 6eme Bataillon d'Infanterie de Mar   (Gabon)

Author keywords

Central Africa; Chemosusceptibility; Chloroquine proguanil association; Gabon; Libreville; Malaria; Plasmodium falciparum; Resistance

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; CYCLOGUANIL; TRIAZINE DERIVATIVE;

ADOLESCENT; ANIMAL; ARTICLE; CHILD; DRUG EFFECT; DRUG RESISTANCE; GABON; HUMAN; INFANT; MALARIA FALCIPARUM; PARASITOLOGY; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD;

ADOLESCENT; ANIMALS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG RESISTANCE; GABON; HUMANS; INFANT; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; TRIAZINES;

EID: 0033128774     PISSN: 00379085     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. ADERA T, WOLFE MS, MCGUIRE-RUGH K, CALHOUN N & MARUM L - Risk factors for malaria among expatriates living in Kampala, Uganda: the need for adherence to chemoprophylactic regimens. Am J Trop Med Hyg, 1995, 52, 207-212.
2. AGNAMEY P, LEROY G, KOUAMOUO J & BRASSEUR P - Sensibilité in vivo et in vitro de Plasmodium falciparum à la chloroquine et à l'amodiaquine à Bangangte (Ouest Cameroun). Bull Soc Pathol Exot, 1995, 88, 149-151.
3. AMUKOYE E, WINSTANLEY PA, WATKINS WM, SNOW RW, HATCHER J et al. - Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria. Antimicrob Agents Chemother, 1997, 41, 2261-2264.
4. ANABWANI GM, ESAMAI FO & MENYA DA - A randomised controlled trial to assess the relative efficacity of chloroquine, amodiaquine, halofantrine and Fansidar in the treatment of uncomplicated malaria in children. East Afr Med J, 1996, 73, 155-158.
5. BARNES AJ, ONG EL, DUNBAR EM, MANDAL BK & WILKINS EGL - Failure of chloroquine and proguanil prophylaxis in travellers to Kenya. Lancet, 1991, 338, 1338-1339.
6. BASCO LK, ELDIN DE PECOULAS P, WILSON CM, LE BRAS J & MAZABRAUD A - Point mutations in the dihydrofolate reductase-thymidylate synthetase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol Biochem Parasitol, 1995, 69, 135-138.
7. BEM JL, KERR L & STUERCHLER D - Mefloquine prophylaxis : an overview of spontaneous reports of severe psychiatric reactions and convulsions. J Trop Med Hyg, 1992, 95, 167-179.
8. BRABIN BJ, VERHOEFF FH, KAZEMBE P, CHIMSUKU L & BROADHEAD R - Antimalarial drug policy in Malawi. Ann Trop Med Parasitol, 1997, 91, 113-115.
9. BRANDICOURT O, CARME B, GAY F, TURK P & GENTILINI M -Widespread in vitro resistance to chloroquine of Plasmodium falciparum in the Congo, 1987. Trop Med Parasitol, 1991, 42, 55-59.
10. BRASSEUR P, AGNAMEY P, EKOBO AS, SAMBA G, FAVENNEC L & KOUAMOUO J - Sensitivity of Plasmodium falciparum to amodiaquine and chloroquine in central Africa: a comparative study in vivo and in vitro. Trans R Soc Trop Med Hyg, 1995, 89, 528-530.
11. CALI G - The Italian Army Medical Corps in the United Nations "peace-keeping" operations: Somalia and Mozambique, December 1992 - December 1994. Méd Trop, 1996, 56, 400-403.
12. CARME B, PEGUET C S & NEVEZ G - Compliance with and tolerance of mefloquine and chloroquine + proguanil malaria chemoprophylaxis in French short-term travellers to sub-Saharan Africa. Trop Med Intern Health, 1997, 2, 953-956.
13. CHANDENIER J, NDOUNGA M, CARME B, GAY F, MBITSI A et al.-Chimiosensibilité in vivo et in vitro de Plasmodium falciparum à Brazzaville (Congo). Cahiers Santé, 1995, 5, 25-29.
14. CLATTENBURG RN & DONNELLY CL - Case study: neuropsychiatric symptoms associated with the antimalarial agent mefloquine. J Am Acad Child Adolesc Psychiatry, 1997, 36, 1606-1608.
15. COROMINAS N, GASCON J, MEJIAS T, CAPARROS F & QUINTO L -Adverse effects associated with antimalarial chemoprophylaxis. Med Clin (Barc), 1997, 108, 772-775.
16. CROFT AM, CLAYTON TC & WORLD MJ - Side effects of mefloquine prophylaxis for malaria: an independant randomized controlled trial. Trans R Soc Trop Med Hyg, 1997, 91, 199-203.
17. CSHP (Conseil Supérieur d'Hygiène Publique de France) - Recommandations sanitaires pour les voyageurs. BEH, 1997, 26, 119.
18. ERKSSON B, BJORKMAN A & KEISU M - How safe is proguanil? A post-marketing investigation of side-effects. Scand J Infect Dis, 1991, 23, 489-493.
19. GOZAL D, HENGY C & FADAT G - Prolonged malaria prophylaxis with chloroquine and proguanil (chloroguanide) in a nonimmune resident population of an endemic area with a high prevalence of chloroquine resistance. Antimicrob Agents Chemother, 1991, 35, 373-376.
20. HOEBE C, DE MUNTER J & THUS C - Adverse effects and compliance with mefloquine or proguanil antimalarial chemoprophylaxis. Eur J Clin Pharmacol, 1997, 52, 269-275.
21. HOWELLSRE, GILLES HM & BENT NS - A comparison of the pyrimethamine and cycloguanil sensitivities of the pre-erythrocytic and erythrocytic stages of drug-sensitive and drug-resistant strains of Plasmodium yoelii. Ann. Trop. Med. Parasitol., 1985, 79, 247-251.
22. KREMSNER PG, WINKLER S, BRANDTS C, GRANIGER W & BIENZLE U -Curing of chloroquine-resistant malaria with clindamycin. Am J Trop Med Hyg. 1993, 49, 650-654.
23. LOBEL HO & KOZARSKY PE - Update on prevention of malaria for travelers. J Am Med Assoc, 1997, 278, 1767-1771.
24. LOOREESUWAN S, VIRAVAN C, WEBSTER HK, KYLE DE, HUTCHINSON DB & CANFIELD CJ - Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg, 1996, 54, 62-66.
25. LUZZI GA & PETO TE - Adverse effects of antimalarials. An update. Drug Saf, 1993, 8, 295-311.
26. MARTIN J, MORAND C, M'BAYE PS, OGER E & ABGRALL J - Résis-tance de Plasmodium falciparum à l'association chloroquine-proguanil : un cas en provenance du Bénin. Presse Méd, 1992, 21, 678.
27. MILLER JH, BYERS M, WHITEOAK R & WARREL DA - Imported falciparum malaria in British troops returning from Kenya. J R Army Med Corps, 1994, 140, 119-123.
28. NZILA-MOUNDA A, MBERU EK, SIBLEY CH, PLOWE CV, WINSTANLEY PA & WATKINS WM - Kenyan Plasmodium falciparum field isolates : correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in dihydrofolate reductase domain. Antimicrob Agents Chemother, 1998, 42, 164-169.
29. OMS - Voyages internationaux et santé. Vaccinations exigées et conseils d'hygiène. Genève, Org mond de la Santé, 1997, 112 p.
30. PARZY D, DOERIG C, PRADINES B, RICO A, FUSAI T & DOURY JC -Proguanil resistance in Plasmodium falciparum isolates: assessment by mutation-specific PCR and in vitro susceptibility testing. Am J Trop Med Hyg, 1997, 57, 646-650.
31. PERAGALLO MS, SABATINELLI G, MAJORI G, CALI G & SARNICOLA G - Prevention and morbidity of malaria in non-immune subjects; a case-control study among Italian troops in Somalia and Mozambique, 1992-1994. Trans R Soc Trop Med Hyg, 1997, 91, 343-346.
32. PRADINES B, ROGIER C, FUSAI T, TALL A, TRAPE JF & DOURY JC -Sensibilité in vitro de 85 isolats de Plasmodium falciparum dans la région de Fatick, Sénégal. Méd Trop, 1996, 56, 141-145.
33. RADLOFF PD, PHILIPPS J, NKEYI M, HUTCHINSON D & KREMSNER PG -Atovaquone and proguanil for Plasmodium falciparum malaria, Lancet, 1996, 447, 1511-1514.
34. VAN RIEMSDIJK MM, VAN DER KLAUW MM, PEPPLINKHUIZEN L & STRICKER BH - Spontaneous report of psychiatric effects to mefloquine in the Netherlands. Br J Clin Pharmacol, 1997, 44, 105-107.
35. VAN RIEMSDUK MM, VAN DER KLAUW MM, VAN HEEST JA, REEDEKER FR & LIGTHELM RJ - Neuro-psychiatric effects of antimalarials. Eur J Clin Pharmacol, 1997, 52, 1-6.
36. SARROUY J, CELLIER C, MIGLIANI R, TODESCO A, FAVIER G et al.-Chimioprophylaxie du paludisme à Plasmodium falciparum par une association de 100 mg de chloroquine et 200 mg de proguanil par jour dans une zone III de chloroquinorésistance (Gabon). Bull Soc Pathol Exot, 1991, 84, 80-93.
37. SOKHNA CS, MOLEZ JF, NDIAYE P, SANE B & TRAPE JF - Tests in vivo de la chimiosensibilité de Plasmodium falciparum à la chloroquine au Sénégal : évaluation de la résistance et estimation de l'efficacité thérapeutique. Bull Soc Pathol Exot, 1997, 90, 83-89.
38. WARD SA, WATKINS WM, MBERU E, SAUNDERS JE & KOECH DK -Inter-subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man. Br J Clin Pharmacol, 1989, 27, 781-787.
39. WATKINS WM, MBERU EK, NEVILL CG, WARD SA & BRECKENRIDGE - Variability in the metabolism of proguanil to the active metabolite cycloguanil in healthy Kenyan adults. Trans R Soc Trop Med Hyg, 1990, 84, 492-495.
40. WEISS T, OLOO AJ, JOHNSON A, KOECH D & HOFFMAN SL - Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus proguanil. J Infect Dis, 1995, 171, 1569-1575.
41. WETSTEYN JC & DE GEUS A - Comparison of three regimens for malaria prophylaxis in travellers to East Central, and Southern Africa. Br Med J, 1993, 307, 1041-1043.
42. WETSTEYN JC & DE GEUS A - Comparison of three malaria chemoprophylactic regimens in residents in East, Central and Southern Africa. A prospective, randomized multicentre trial in the Netherlands. Trop Geogr Med, 1995, 47, 103-106.
43. WINKLER S, BRANDTS C, WERNSDORFER WH, GRANIGER W, BIENZLE U & KREMSNER PG - Drug sensitivity of Plasmodium falciparum in Gabon. Activity correlations between various antimalarials. Trop Med Parasitol, 1994, 45, 214-218.
44. WOLDAY D, KIBREAB T, BUKENYA D & HODES R - Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyrimethamine-sulfadoxine in Rwandan patients in a refugee camp in Zaire. Trans R Soc Trop Med Hyg, 1995, 89, 654-656.